ANAPTYSBIO, INC — Director's Dealing 2017

Jan 26, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ANAPTYSBIO INC (ANAB)
CIK: 0001370053
Period of Report: 2017-01-25

Reporting Person: Gallagher Carol Giltner (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series C Preferred Stock	$0.00		Common Stock (42857)		Direct
Series D Preferred Stock	$0.00		Common Stock (21439)		Direct
Director Stock Option (right to buy)	$1.12	2021-12-08	Common Stock (97722)		Direct

Footnotes

F1: Each share of Preferred Stock will be automatically converted into one (1) share of Common Stock, for no additional consideration, immediately prior to the consummation of the Issuer's initial public offering, and has no expiration date.

F2: The stock option is fully vested and immediately exercisable.